LabPulse.com
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
  • Sign In
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
Stay in the Know
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Business Insights
  • Policy & Regulation
  • Trends & Finance
Research & Development
  • Clinical Trials
  • Collaboration
  • Funding
Diagnostic Technologies
  • Clinical Chemistry
  • Emerging Technology
  • Immunoassays
  • Molecular Diagnostics
  • Pathology & AI
Diseases
  • Autoimmune
  • Cancer
  • Cardiovascular
  • COVID-19
  • Health Topics
  • Infectious
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
User Tools
  • Sign In
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon
  • Business Insights
    • Policy & Regulation
    • Trends & Finance
  • Diagnostic Technologies
    • Clinical Chemistry
    • Emerging Technology
    • Immunoassays
    • Molecular Diagnostics
    • Pathology & AI
  • Diseases
    • Autoimmune
    • Cancer
    • Cardiovascular
    • COVID-19
    • Health Topics
    • Infectious
  • Point-of-Care Testing
  • Research & Development
    • Clinical Trials
    • Collaboration
    • Funding
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
  • Sign In
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon

Site Map

  1. 2023
  2. March
  3. 27
OraSure, nRichDx to offer products for researchers developing urine-based liquid biopsy assays
Serum protein in study predicted which patients might die without a liver transplant
Calibre Scientific acquires U.K. provider of scientific equipment, supplies, services
Biolytical Laboratories nabs Health Canada authorization for HIV-1/2 syphilis antibody test
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
Illumina NGS software to enable tertiary analysis for oncology, rare disease
What to do when genetic tests reveal links to cardiovascular disease: Scientific statement
Page 1 of 1
LabPulse.com
Stay Connected
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Sign Up
Topics
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon
  1. Privacy Policy
  2. Contact Us
  3. Site Map
© 2023 Science and Medicine Group. All rights reserved.